Rosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW264.7 cells (ロスマリン酸とアルブチンはスーパーオキシド 除去作用と NFATc1 の発現抑制によって RAW264.7 細胞からの破骨細胞分化を抑制する) 平成 26 年 3 月申請 北海道大学 大学院歯学研究科口腔病態学専攻 大 森 晶 奈 ABSTRACT : We investigated the effect of the natural polyphenols rosmarinic acid and arbutin on osteoclast differentiation in RAW 264.7 cells. Rosmarinic acid and arbutin suppressed osteoclast differentiation and had no cytotoxic effect on osteoclast precursor cells. Rosmarinic acid and arbutin inhibited superoxide production and intracellular superoxide in a dose dependent manner. mRNA expression of the master regulator of osteoclastogenesis, nuclear factor of activated T cells cytoplasmic1 (NFATc1), and the osteoclast marker genes, matrix metalloproteinase-9, tartrate-resistant acid phosphatase and cathepsin-K, decreased after treatments with rosmarinic acid and arbutin. Furthermore, resorption activity decreased with the number of osteoclasts. These results suggest that rosmarinic acid and arbutin may be useful for the prevention and treatment of bone diseases such as osteoporosis through mechanisms involving inhibition of superoxide and down-regulation of NFATc1.
Introduction
Polyphenols are aromatic and slightly bitter-tasting compounds in vegetables, fruits and herbs. It has been reported that polyphenols can prevent several chronic diseases such as arteriosclerosis, cardiovascular diseases and cancer due to their antioxidant activity [1] [2] [3] . The most well-known study associated with polyphenols is the investigation called the French paradox. The French paradox is the epidemiological observation that French people have a low incidence of coronary heart disease despite a diet high in saturated fat, and is generally attributed to the high concentration of polyphenols in red wine 4, 5) .
Recent studies have shown that polyphenols not only prevent arteriosclerosis and cancer, but also affect bone diseases by suppressing osteoclast differentiation and increasing bone mineral density in ovariectomized mice 6, 7) . Several polyphenols such as curcumin, resveratrol and plum polyphenol can scavenge reactive oxygen species (ROS) associated with osteoclast differentiation [8] [9] [10] . Rosmarinic acid is a natural polyphenol contained in Lamiaceae herbs such as Perilla frutescens, lemon balm mint, sage and sweet basil 11) . In particular, rosmarinic acid is effective against allergies, exhibits anti-inflammatory properties, and is used in health foods 12, 13) . Arbutin is a natural polyphenol contained in plants such as Ericaceae, Asteraceae and Vaccinium 14) .
Arbutin has recently been reported to exert a potent inhibitory effect on the hydroxylation reaction of tyrosinase and has been widely used for skin whitening 15, 16) .
Osteoclasts are members of the monocyte/macrophage lineage and are formed by fusion of their precursor cells. The receptor activator of nuclear factor-kB ligand (RANKL) is the most essential cytokine for the process of osteoclast differentiation and activation 17) .
RANKL is a member of the tumor necrosis factor (TNF) family and is expressed as a membrane-bound protein in osteoblast and stromal cells. Binding of RANKL with the receptor RANK induces activation of TNF receptor-associated factor (TRAF6) and the c-Fos pathway. This activates downstream signaling pathways involving the nuclear factor of activated T cells cytoplasmic 1 (NFATc1) and leads to the formation of tartrate-resistant acid phosphatase (TRAP) positive osteoclasts 18) .
The murine macrophage/osteoclast precursor cell line, RAW 264.7 (RAW), is a widely used pre-osteoclast model. RAW cells differentiate into osteoclasts in the presence of RANKL. Bone is continuously and precisely remodeled by the coordination of bone-forming osteoblasts and bone-resorbing osteoclasts 19) . Osteoporosis is characterized by reduced bone mass and diminished bone integrity caused by an imbalance between osteoblasts and osteoclasts 20) .
ROS contribute to the aging process and the etiology of various degenerative diseases, including osteoporosis 21) . Moreover, osteoclasts have been shown to be activated by ROS, resulting in enhanced bone resorption. On the other hand, ROS also play an important role as secondary messengers in osteoclast signaling pathways 22) . ROS are generated by superoxide production of NADPH oxidase in a process called the respiratory burst. Approximately 3-10% of the oxygen utilized by tissues is converted to ROS, including superoxides 23) . A recent study reported that rosmarinic acid inhibited phorbol myristate acetate (PMA)-induced superoxide production in a macrophage cell line 24) . Arbutin has been shown to inhibit ultraviolet A (UVA) irradiation-induced ROS in skin cells 25) .
Rosmarinic acid has been shown to inhibit NF-κB activation during osteoclast formation 26) . However, with the exception of this mechanism of action of rosmarinic acid, the inhibitory effects of polyphenols on osteoclasts remain unknown. In particular, the therapeutic effects of arbutin on bone have not been studied. The purpose of this study was to investigate the effects of rosmarinic acid and arbutin on the differentiation and formation of osteoclasts from RAW cells through suppression of the superoxide-mediated signaling pathway. We hypothesized that these polyphenols would downregulate NFATc1, resulting in the direct inhibition of osteoclastogenesis, and lead to a decrease in osteoclast resorption activity.
Materials and methods

Chemicals.
RAW cells were purchased from ATCC (Manassas, VA, USA). Cell culture. The murine monocyte/macrophage cell line RAW was used as osteoclast precursor cells. RAW cells differentiate into osteoclasts in the presence of RANKL (50 ng/ml). RAW cells were grown in DMEM medium supplemented with 10% heat-inactivated FBS and 66.7 μg/ml kanamycin-sulfate (Meiji Seika, Tokyo, Japan).
Rosmarinic
The cells were seeded onto 100-mm standard dishes (BD Falcon, Franklin Lakes, NJ).
After overnight culture, the cells were cultured in α-MEM supplemented with 10% heat-inactivated FBS, RANKL, 284 μM ascorbic acid 2-phosphate, 2 mM L-alanyl-L-glutamine and 66.7 μg/ml kanamycin-sulfate. They were then treated with or without rosmarinic acid or arbutin at the concentrations indicated below. These cultures were fed every other day by replacing the old medium with an identical volume of fresh medium. All cultures were incubated at 37°C in a humidified 5% CO 2 , 95% air atmosphere .
MTT assay for cell viability. A Vialight TM Kit (Lonza, Allendale, NJ) was used to measure the viability of RAW cells exposed to rosmarinic acid or arbutin. This kit utilizes the ATP present in live cells in a luciferase-catalyzed reaction to produce light.
RAW cells were seeded on a 96-well plate (BD) at a density of 0.25 ×10 4 cells/well and treated with rosmarinic acid or arbutin without RANKL for 72 h. After culture, the cells were lysed in 50 μl of cell lysis solution. After incubation for 15 min at room temperature, the cell lysates were transferred to a luminescence plate (Nunc, Roskilde, Denmark) and mixed with 100 μl AMR PLUS reagent. After 2 min incubation at room temperature in the dark, the plate was read on a luminescence plate reader (Wallac 1420
ARVOsx, Perkin Elmer, Waltham, MA). The luminescence measured from each treatment group was converted to a percentage of the luminescence measured from the control cells (no rosmarinic acid or arbutin added).
Tartrate-resistant acid phosphatase (TRAP) staining. Osteoclasts were assessed by cytochemical staining for TRAP. RAW cells were seeded on a 48-well plate (BD) at a density of 0.5 × 10 4 cells/well and treated with RANKL and rosmarinic acid or arbutin.
After 6 days, the cells were fixed with 10% neutral formalin. They were then washed with distilled water and stained in TRAP staining solution (pH 5.0) with Fast Red Violet LB salt 27) . TRAP-positive osteoclasts with more than 2 nuclei were considered to be osteoclasts. Osteoclasts with 8 nuclei or more were considered to be large osteoclasts.
The number of osteoclasts was counted under a light microscope.
Measurement of superoxide. Superoxide concentration was measured using a Green
Chemiluminescence CD kit according to the manufacturer's instructions. Green
Chemiluminescent CD is a highly sensitive chemiluminescence probe which reacts with the superoxide anion and a luminescence dye specific for the detection of superoxide.
Briefly, 0.5 × 10 4 cells/well were seeded on a 48-well plate and treated with RANKL 
Results
Effect of rosmarinic acid and arbutin on cell viability in osteoclast precursor cells.
In order to investigate the potential cytotoxicity of rosmarinic acid and arbutin on RAW cells as osteoclast precursors, cell viability was examined using the MTT assay (Fig. 2) . concentrations of rosmarinic acid and arbutin tested had no effect on SOD inhibition ( Fig. 4E and F) .
Effect of rosmarinic acid and arbutin on mRNA expression of osteoclastic specific genes.
Rosmarinic acid and arbutin suppressed RANKL-induced expression of osteoclastogenesis in a dose-dependent manner after 24 h.
Rosmarinic acid and arbutin inhibited RANKL-induced resorption by the pit area.
Rosmarinic acid and arbutin decreased resorption by the pit area in a dose-dependent manner ( Fig. 6A and B) . Resorption by the pit area decreased in line with the number of osteoclasts, suggesting that rosmarinic acid and arbutin primarily affect osteoclast differentiation as opposed to activity.
Discussion
We reported that rosmarinic acid and arbutin at non-toxic concentrations suppress the number of TRAP-positive osteoclasts and large osteoclasts from RAW cells. The results clearly suggest that rosmarinic acid and arbutin suppress osteoclast formation by directly acting on osteoclast precursor cells. Rosmarinic acid has previously been reported to suppress osteoclast differentiation of murine bone marrow-derived macrophages (BMM) and RAW cells 26) . However, the regulation by rosmarinic acid of osteoclast differentiation needs to be further defined. Arbutin has not previously been reported to inhibit osteoclast differentiation or to show a beneficial effect on bone. We report for the first time that arbutin inhibits osteoclast differentiation of RAW cells.
Specially, the inhibitory effects of rosmarinic acid at 20 μM concentration is similar to the inhibitory effect of arbutin at 25 μM: 21.54% caused by 20 μM rosmarinic acid and 22.19% caused by 25 μM arbutin. Furthermore, rosmarinic acid has been reported to be more potent for ROS removal compared to arbutin in the mesenteric artery in rats 28) .
Therefore, we investigated whether the antioxidant reaction of rosmarinic acid and arbutin can regulate osteoclast differentiation.
ROS was recently recognized as a second messenger in the differentiation of osteoclasts and plays an important role in differentiation 22) . On the other hand, excessive ROS production results in an abnormal osteoclast phenomenon: the activation of osteoclast signals due to an increase in the number of osteoclasts. (29) Moreover, ROS production by osteoporotic bone tissue has been shown to be significantly higher than in normal bone tissue 30) . Several studies have reported that the ROS level increases during RANKL-induced osteoclast differentiation, and that this ROS generation can be attenuated by polyphenols such as curcumin and resveratrol 8, 9) . In addition, the antioxidants scopoletin and scopolin inhibit ROS and superoxide production in a dose-dependent manner 31) . A superoxide is converted into various ROS such as hydroxyl radical ( • OH), hydrogen peroxide (H 2 O 2 ) and peroxynitrite (ONOO-) in the process of formation of the osteoclasts 32, 33) . Thus, to investigate whether rosmarinic acid and arbutin can inhibit superoxide generation during osteoclast differentiation, the production of superoxide and the intracellular levels of superoxide were analyzed.
According to the sucopoletin and scopolin study referred to above, the intracellular ROS level increased to its highest value within 48 h and then decreased 31) . Therefore, we also analyzed superoxide levels after treating the cells with rosmarinic acid and arbutin for 48 h and showed that rosmarinic acid and arbutin reduced superoxide production and intracellular superoxide in a dose-dependent manner. Most importantly, rosmarinic acid and arbutin inhibited superoxide, but had no effect on RANKL-induced SOD activity, suggesting rosmarinic acid and arbutin have a positive effect on RANKL-induced superoxide removal. The antioxidant activity of rosmarinic acid and arbutin have been observed using various cells. Rosmarinic acid inhibits ROS production in several cell lines such as dopaminergic cells and hematoma cells 34, 35) .
Rosmarinic acid also inhibits PMA-induced intracellular superoxide in macrophage cell lines, and has no effect on Cu/Zn SOD 24) . Arbutin suppresses UVA-induced ROS on cellular tyrosinase activity, primarily in skin cells such as human and mice melanocytes 25, 36) . Additionally, curcumin suppresses phosphor I-κBα and intracellular ROS production in the osteoclast differentiation process in a dose-dependent manner 8) .
Curcumin also completely suppresses NF-κB activity in the osteoclast differentiation process 37) . Rosmarinic acid shares common structural features with curcumin, so we can speculate that rosmarinic acid acts by a similar mechanism to inhibit RANKL-induced production of ROS such as superoxide. Furthermore, it was previously demonstrated that rosmarinic acid inhibits RANKL-induced NF-κB activation in the osteoclast differentiation process in BMM 26) . Arbutin suppresses NF-κB activity in BV2 microglial cells 38) . Further investigation is required to ascertain whether inhibition of NF-κB activity plays a role in suppression of osteoclast differentiation from RAW cells by rosmarinic acid and arbutin.
Taken together, our results show that rosmarinic acid and arbutin decrease RANKL-induced expression of NFATc1 mRNA. NFATc1 is a master regulator of RANKL-induced osteoclast differentiation 39) . NFATc1 plays a pivotal role in osteoclast activation via up-regulation of various genes in a series processes, such as osteoclast adhesion, migration, acidification and degradation of inorganic and organic bone matrix 18) . Thus, we investigated the effect of rosmarinic acid and arbutin on the mRNA expression of the osteoclast marker genes, MMP-9, TRAP and cathepsin-K, in osteoclasts. The mRNA expression of MMP-9, TRAP and cathepsin-K also were suppressed by the addition of rosmarinic acid and arbutin. MMP-9 is essential for initiating the osteoclastic resorption process by removing the collagenous layer from the bone surface prior to demineralization 40) . Furthermore, expression of MMP-9 in osteoclast is markedly higher than in other cell types 41) . Tea polyphenols suppress osteoclast formation and activity by inhibiting the production of free radicals and MMP-9, and inducing apoptosis 42) . TRAP is a marker for osteoclasts, and there is increasing evidence of its proteolytic role in bone resorption 43) . TRAP knock-out mice have shown that bone shape and modeling are altered by increased mineral density, suggesting that TRAP plays an important role in bone resorption 44) . Cathepsin-K activity is required for the initial formation of actin rings and thus for the activation of osteoclasts 45) . A NFATc1 knock-out mouse study has reported that the endocardia expression of NFATc1 is dependent on the expression of cathepsin-K 46) . Based on these findings, we hypothesized that rosmarinic acid and arbutin might suppress the resorption activity of osteoclasts. To investigate the effect of resorption activity of osteoclasts treated with rosmarinic acid and arbutin, we treated cells with rosmarinic acid and arbutin after 11 days of culture using Corning osteo assay surface plates. Pit assays compared the pit area after treatment with rosmarinic acid and arbutin to that of the controls, suggesting that rosmarinic acid and arbutin impair the resorption activity of osteoclasts.
It is critical to investigate the effect of compounds in vivo rather than in vitro. More studies are therefore required to test the beneficial bone effects of rosmarinic acid and arbutin in animal models and human studies. From the viewpoint of clinical applications, it has been reported that the concentration of rosmarinic acid in the plasma of goat kids fed a diet containing 140.44 mg/kg or 273.86 mg/kg rosmarinic acid for 224 days was 0.78 mg/L and 0.81 mg/L, respectively 47) . Our results suggest that such plasma concentrations can significantly inhibit osteoclasts. Rosmarinic acid, as well as other polyphenols such as caffeic acid and ferulic acid, is metabolized when taken orally 48) .
A rat serum concentration of 1.36 μmol/min/L was obtained by dosing 100 μmol/kg/body weight rosmarinic acid 49) . These reports apparently show the effective concentration difference between in vitro and blood concentrations. The blood levels of arbutin have not been reported. However, arbutin is used as a traditional medicine for treating urinary tract infections, thereby confirming its safety when taken orally 50) .
In summary, we analyzed the effect of rosmarinic acid and arbutin on osteoclast differentiation by studying their inhibition of RANKL-induced superoxide, which is the source of ROS generation. Rosmarinic acid and arbutin inhibited osteoclast formation by blocking osteoclast marker genes such as MMP-9, TRAP and chathepsin-K via downregulation of NFATc1. These findings strongly suggest that rosmarinic acid and arbutin hold promise for the treatment of various bone diseases such as osteoporosis and bone metastasis associated with excessive bone resorption. 
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